• Cy3 NHS ester (non-sulfonated): Protocol Guide

  2026-08-13

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent label for amino groups on proteins, peptides, and nucleic acids when the workflow can tolerate an organic co-solvent. It is not appropriate for aqueous-only labeling or biomolecules that are sensitive to DMSO or DMF; a water-soluble sulfo-Cy3 NHS ester is a better choice in those cases.

• Açaí Extracts: Hepatocyte Cytotoxicity and Induction

  2026-08-13

  Raichura and colleagues evaluated consumer-relevant açaí extracts in sandwich-cultured human hepatocytes and complementary transporter assays. The study found extract-specific, time- and dose-dependent cytotoxicity, but little evidence of induction of major CYP enzymes or drug transporters, refining how botanical–drug interaction risks should be interpreted.

• ARCA Capped mRNA Synthesis with HyperScribe

  2026-08-12

  Discover how the HyperScribe All in One mRNA Synthesis Kit Plus 1 integrates ARCA capping, modified nucleotides, DNase treatment, and poly(A) tailing. This article connects molecular design choices to assay controls and emerging RNA vaccine development evidence.

• CCR7/DUSP1–iCAF Axis in HNSCC Growth

  2026-08-12

  The reference study connects CCR7 signaling in inflammatory cancer-associated fibroblasts with DUSP1 expression, TGF-β1 secretion, and head and neck squamous cell carcinoma behavior. Its integrated single-cell, cell-sorting, genetic perturbation, co-culture, and functional-assay design provides a mechanistic framework for studying how stromal cell states regulate tumor growth.

• SERCA2–CaN/FoxO1/FABP4 Axis in Atherosclerosis

  2026-08-11

  This 2025 study identifies the calcineurin/FoxO1/FABP4 pathway as a mechanistic link between SERCA2 dysfunction, abnormal macrophage lipid handling, foam cell formation, and atherosclerosis. Its combination of a SERCA2 C674S knock-in model, macrophage assays, metabolomics, and pharmacological intervention supports FABP4 inhibition as a strategy for testing how lipid metabolism contributes to vascular inflammation.

• FNPs for Stable Lung-Specific mRNA Delivery

  2026-08-11

  The reference study introduces five-element nanoparticles (FNPs) that combine poly(β-amino ester) helper polymers with DOTAP to improve both lung-directed mRNA delivery and formulation stability. Its structure–activity analysis and lyophilization results indicate a practical route toward mRNA formulations that retain activity during refrigerated storage.

• Netarsudil (AR-13324) for Reliable Cell Assays

  2026-08-10

  A scenario-based guide to using Netarsudil (AR-13324), SKU B7807, in cell viability, proliferation, cytotoxicity, and cytoskeletal workflows. It explains how ROCK biology, formulation properties, controls, and data interpretation affect reproducibility, while connecting the compound to emerging siRNA codelivery research.

• Eicosapentaenoic Acid (EPA): Mechanisms & Research

  2026-08-09

  Eicosapentaenoic Acid is an EPA omega-3 fatty acid used to study membrane remodeling, lipid oxidation, vascular signaling, and inflammation. Product data support defined identity, high typical purity, and concentration-dependent in vitro effects, but these findings do not establish EPA as a clinical treatment or vaccine adjuvant.

• HGFA Biomarker Discovery in Pulmonary Arterial Hypertension

  2026-08-08

  Zhang et al. integrated serum iTRAQ proteomics, ELISA, ROC analysis, Mendelian randomization, and two pulmonary hypertension models to identify hepatocyte growth factor activator (HGFA) as a candidate biomarker for pulmonary arterial hypertension. HGFA showed the strongest diagnostic discrimination among three altered proteins and was supported by genetic and animal-model evidence, although prospective clinical validation and mechanistic studies remain necessary.

• SU5416 (Semaxanib) for Angiogenesis Research

  2026-08-07

  SU5416 (Semaxanib) provides a selective way to interrogate VEGFR2 signaling in endothelial, tumor, and pulmonary hypertension models. This workflow-focused guide connects VEGF-induced angiogenesis inhibition with cardiopulmonary phenotyping, assay controls, and practical troubleshooting.

• 5-Azacytidine: Applied Protocols and Innovations in Cancer E

  2026-08-07

  5-Azacytidine (5-AzaC) is transforming cancer research as a DNA demethylation agent, enabling precise modulation of gene expression and cell fate. This article details hands-on workflows, advanced experimental strategies, and troubleshooting insights to maximize reproducibility and translational value with APExBIO’s 5-Azacytidine, drawing from the latest breakthroughs in metastasis suppression.

• RSL3 Glutathione Peroxidase 4 Inhibitor: Protocols & Innovat

  2026-08-06

  Discover how the (1S,3R)-RSL3 glutathione peroxidase 4 inhibitor empowers cancer research through precise ferroptosis induction, synthetic lethality with oncogenic RAS, and robust modulation of oxidative stress. This guide delivers advanced workflow enhancements, actionable protocol parameters, and troubleshooting tips for maximizing the impact of RSL3 in preclinical studies.

• AM251 in Neuroscience: Beyond CB1 Antagonism to Functional I

  2026-08-06

  Explore the multifaceted applications of AM251 as a CB1 receptor antagonist in neuroscience research. This article uniquely analyzes mechanistic depth, translational assay design, and practical considerations, providing actionable insights for cannabinoid receptor studies.

• Optimizing mRNA Synthesis: Applied Uses of Pseudo-UTP

  2026-08-05

  Pseudo-modified uridine triphosphate (Pseudo-UTP) transforms mRNA workflows by enhancing RNA stability, translation, and reducing immunogenicity. This guide provides actionable protocols, troubleshooting insights, and highlights from cutting-edge vaccine research to help researchers maximize the impact of Pseudo-UTP in mRNA vaccine and gene therapy applications.

• Septin4 Accelerates Hypoxic Cardiomyocyte Injury via HIF-1α

  2026-08-05

  This study reveals that Septin4 exacerbates hypoxia-induced cardiomyocyte apoptosis by promoting von Hippel-Lindau (VHL)-mediated ubiquitination and degradation of HIF-1α. These findings provide new mechanistic insights into myocardial ischemia and identify novel intervention points for therapeutic strategies targeting HIF-1α stability.

16385 records 1/1093 page Next 12345 下5页 Last page